[Expert Solution]: You are a pharmacist practicing in a…

You are a pharmacist practicing in a pulmonology clinic. The medical director would like to create a policy regard- ing which patients with asthma should receive biomarker testing. Which one of the following is best to recommend for inclusion in the clinic policy? A. Uncontrolled symptoms despite high-dose inhaled corticosteroid (ICS); diagnosis of allergic asthma B. Uncontrolled symptoms despite high-dose ICS plus long-acting beta 2-agonist (ICS/LABA); PDC greater than 80%; adequate inhaler technique C. Uncontrolled symptoms despite medium-dose ICS/ LABA plus a daily oral corticosteroid (OCS) D. Uncontrolled symptoms despite high-dose ICS/LABA; 1 or more exacerbations in the past 24 months